Celularity Inc — Investor Relations & Filings
Celularity Inc. is a clinical and commercial-stage biotechnology company specializing in cellular and regenerative medicine. The company develops and commercializes therapies derived from the postpartum human placenta. Its core focus is on creating off-the-shelf, allogeneic cell therapies, including genetically modified and unmodified Natural Killer (NK) cells, CAR T-cells, and mesenchymal-like adherent stromal cells (MLASCs). These therapeutic programs target a range of conditions, including cancer, immune disorders, and aging-related degenerative diseases. In addition to its clinical pipeline, Celularity markets a suite of commercial placenta-derived biomaterial products. The company leverages the unique biological properties of the placenta to develop accessible treatments for significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Celularity Inc (0001752828) (Filer) | 2026-04-21 | English | |
| SCHEDULE 13G/A Filing | 2026-02-11 | English | |
| 8-K Filing | 2026-01-21 | English | |
| 4/A | 2026-01-15 | English | |
| 4/A | 2026-01-15 | English | |
| 4/A | 2026-01-15 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 34774203 | 8-K - Celularity Inc (0001752828) (Filer) | 2026-04-21 | English | ||
| 31588087 | SCHEDULE 13G/A Filing | 2026-02-11 | English | ||
| 31588249 | 8-K Filing | 2026-01-21 | English | ||
| 13133909 | 4/A | 2026-01-15 | English | ||
| 13133910 | 4/A | 2026-01-15 | English | ||
| 13133912 | 4/A | 2026-01-15 | English | ||
| 13133911 | 4/A | 2026-01-15 | English | ||
| 13133913 | Director's Dealing 2026 | 2026-01-15 | English | ||
| 13133914 | Director's Dealing 2026 | 2026-01-15 | English | ||
| 13133915 | Director's Dealing 2026 | 2026-01-15 | English | ||
| 13133916 | Director's Dealing 2026 | 2026-01-15 | English | ||
| 13133917 | 424B3 | 2026-01-08 | English | ||
| 13133918 | Regulatory Filings 2026 | 2026-01-08 | English | ||
|
2025
2 filings
| |||||
| 13133919 | S-1 | 2025-12-31 | English | ||
| 13133920 | 4 | 2025-12-30 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosim…
|
ALVO | LU | Manufacturing |
|
ALX ONCOLOGY HOLDINGS INC
Clinical-stage immuno-oncology company developing therapies…
|
ALXO | US | Manufacturing |
|
Alzamend Neuro, Inc.
Develops treatments for neurodegenerative diseases and psyc…
|
ALZN | US | Manufacturing |
|
Alzinova AB
Clinical-stage biopharma developing immunotherapies for Alz…
|
ALZ | SE | Manufacturing |
|
Amanta Healthcare Limited
Manufactures sterile liquid formulations using advanced Blo…
|
AMANTA | IN | Manufacturing |
|
AMARIN CORP PLC\UK
Develops and commercializes therapeutics to improve cardiov…
|
AMRN | US | Manufacturing |
|
Ambalal Sarabhai Enterprise Ltd.
Manufactures pharmaceuticals, APIs, fine chemicals, and dia…
|
AMBALALSA | IN | Manufacturing |
|
Ambrilia Biopharma Inc.
Biopharmaceutical company focused on novel treatments for o…
|
AMB | CA | Manufacturing |
|
AMGEN INC
A biotechnology company developing human therapeutics for s…
|
AMGN | US | Manufacturing |
|
Amicogen, Inc.
Industrial biotechnology company specializing in specialty …
|
092040 | KR | Manufacturing |
Celularity Inc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34506/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34506 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34506 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34506 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34506}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Celularity Inc (id: 34506)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.